Cargando…
Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC)
Acute myeloid leukemia (AML) is a life-threatening malignancy that is more prevalent in the elderly. Because the patient population is heterogenous and advanced in age, choosing the optimal therapy can be challenging. There is strong evidence supporting antileukemic therapy, including standard inten...
Autores principales: | Hubscher, Elizabeth, Sikirica, Slaven, Bell, Timothy, Brown, Andrew, Welch, Verna, Russell-Smith, Alexander, D’Amico, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484094/ https://www.ncbi.nlm.nih.gov/pubmed/34462785 http://dx.doi.org/10.1007/s00432-021-03756-7 |
Ejemplares similares
-
Underidentification and Undertreatment Issues
por: Bottorff, Michael B.
Publicado: (2003) -
NIC23
por: Baxter, David, et al.
Publicado: (2013) -
Chromosomal rearrangements in acute myeloid leukemia (AML)
por: Belloni, E, et al.
Publicado: (2010) -
New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020) -
AngioCRIME in Acute Myeloid Leukemia (AML)
por: Macintyre, Elizabeth
Publicado: (2017)